436 related articles for article (PubMed ID: 22022175)
21. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
Erb S; Frei R; Strandén AM; Dangel M; Tschudin-Sutter S; Widmer AF
Clin Microbiol Infect; 2015 Nov; 21(11):998.e9-998.e15. PubMed ID: 26232535
[TBL] [Abstract][Full Text] [Related]
22. Predictive factors, outcomes, and molecular epidemiology of Clostridioides difficile diarrhea in Brazilian hospitals.
Girão ES; de Melo Tavares B; Dos Santos SA; Gamarra GL; Rizek C; Martins RC; Neto LVP; Diogo C; D' Annibale Orsi T; Morales HMP; da Silva Nogueira K; Maestri AC; Boszczowski I; Piastrelli F; Costa CL; Costa DV; Maciel G; Romão J; Guimarães T; de Castro Brito GA; Costa SF
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1821-1832. PubMed ID: 33783664
[TBL] [Abstract][Full Text] [Related]
23. Clostridium difficile: A Frequent Infection in Children After Intestinal Transplantation.
Duclaux-Loras R; Berthiller J; Ferroni A; Chardot C; Goulet O; Lacaille F; Norsa L
Transplantation; 2020 Jan; 104(1):197-200. PubMed ID: 31205257
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of inpatients Clostridium difficile prevalence and risk factors in Cameroon.
Djuikoue IC; Tambo E; Tazemda G; Njajou O; Makoudjou D; Sokeng V; Wandji M; Tomi C; Nanfack A; Dayomo A; Lacmago S; Tassadjo F; Sipowo RT; Kakam C; Djoko AB; Assob CN; Andremont A; Barbut F
Infect Dis Poverty; 2020 Aug; 9(1):122. PubMed ID: 32867842
[TBL] [Abstract][Full Text] [Related]
25. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
Cançado GGL; Silva ROS; Nader AP; Lobato FCF; Vilela EG
J Gastroenterol Hepatol; 2018 Feb; 33(2):393-396. PubMed ID: 28730697
[TBL] [Abstract][Full Text] [Related]
26. Characterization of cases of Clostridium difficile infection (CDI) presenting at an emergency room: molecular and clinical features differentiate community-onset hospital-associated and community-associated CDI in a tertiary care hospital.
Shin BM; Moon SJ; Kim YS; Shin WC; Yoo HM
J Clin Microbiol; 2011 Jun; 49(6):2161-5. PubMed ID: 21471341
[TBL] [Abstract][Full Text] [Related]
27. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
Nitzan O; Elias M; Chazan B; Raz R; Saliba W
World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
[TBL] [Abstract][Full Text] [Related]
28. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
Tunçcan OG; Ulutan F; Karakuş R
Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
[TBL] [Abstract][Full Text] [Related]
29. Clostridium difficile infection at a medical center in southern Taiwan: incidence, clinical features and prognosis.
Chung CH; Wu CJ; Lee HC; Yan JJ; Chang CM; Lee NY; Chen PL; Lee CC; Hung YP; Ko WC
J Microbiol Immunol Infect; 2010 Apr; 43(2):119-25. PubMed ID: 20457428
[TBL] [Abstract][Full Text] [Related]
30. Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection.
Stevens VW; Nelson RE; Schwab-Daugherty EM; Khader K; Jones MM; Brown KA; Greene T; Croft LD; Neuhauser M; Glassman P; Goetz MB; Samore MH; Rubin MA
JAMA Intern Med; 2017 Apr; 177(4):546-553. PubMed ID: 28166328
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and outcome of Clostridium difficile infection by toxin enzyme immunoassay and polymerase chain reaction in an island population.
Kumar S; Pollok R; Muscat I; Planche T
J Gastroenterol Hepatol; 2017 Feb; 32(2):415-419. PubMed ID: 27505006
[TBL] [Abstract][Full Text] [Related]
32. Molecular epidemiologic study of Clostridium difficile infections in university hospitals: Results of a nationwide study in Japan.
Tokimatsu I; Shigemura K; Osawa K; Kinugawa S; Kitagawa K; Nakanishi N; Yoshida H; Arakawa S; Fujisawa M;
J Infect Chemother; 2018 Aug; 24(8):641-647. PubMed ID: 29685855
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China.
Cui Y; Dong D; Zhang L; Wang D; Jiang C; Ni Q; Wang C; Mao E; Peng Y
BMC Infect Dis; 2019 Nov; 19(1):961. PubMed ID: 31711425
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.
Pollock NR; Banz A; Chen X; Williams D; Xu H; Cuddemi CA; Cui AX; Perrotta M; Alhassan E; Riou B; Lantz A; Miller MA; Kelly CP
Clin Infect Dis; 2019 Jan; 68(1):78-86. PubMed ID: 29788296
[TBL] [Abstract][Full Text] [Related]
35. A retrospective study of the epidemiology of Clostridium difficile infection at a University Hospital in Japan: genotypic features of the isolates and clinical characteristics of the patients.
Iwashima Y; Nakamura A; Kato H; Kato H; Wakimoto Y; Wakiyama N; Kaji C; Ueda R
J Infect Chemother; 2010 Oct; 16(5):329-33. PubMed ID: 20449624
[TBL] [Abstract][Full Text] [Related]
36. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
Warren CA; van Opstal EJ; Riggins MS; Li Y; Moore JH; Kolling GL; Guerrant RL; Hoffman PS
Antimicrob Agents Chemother; 2013 Feb; 57(2):689-96. PubMed ID: 23147742
[TBL] [Abstract][Full Text] [Related]
37. Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.
Pilate T; Verhaegen J; Van Ranst M; Saegeman V
Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1741-1747. PubMed ID: 27393490
[TBL] [Abstract][Full Text] [Related]
38. High Prevalence of Toxigenic and Nontoxigenic Clostridium difficile Strains in Malaysia.
Riley TV; Collins DA; Karunakaran R; Kahar MA; Adnan A; Hassan SA; Zainul NH; Rustam FRM; Wahab ZA; Ramli R; Lee YY; Hassan H
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563206
[TBL] [Abstract][Full Text] [Related]
39. Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients.
Søes LM; Brock I; Persson S; Simonsen J; Pribil Olsen KE; Kemp M
Eur J Clin Microbiol Infect Dis; 2012 Feb; 31(2):185-92. PubMed ID: 21744281
[TBL] [Abstract][Full Text] [Related]
40. Detection of Clostridium difficile and its toxin A (TcdA) in stool specimens from hospitalised patients.
Wróblewska MM; Swoboda-Kopeć E; Rokosz A; Nurzyńska G; Bednarska A; Luczak M
Pol J Microbiol; 2005; 54(2):111-5. PubMed ID: 16209104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
